Arcus Biosciences, Inc. (RCUS)

NYSE: RCUS · Real-Time Price · USD

29.52

-0.83 (-2.73%)

At close: Aug 20, 2026, 4:00 PM EDT

29.40

-0.12 (-0.41%)

Pre-market: Aug 21, 2026, 8:12 AM EDT

Arcus Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,759	2,948	1,363	1,430	1,497	2,843
Market Cap Growth	251.07%	116.38%	-4.70%	-4.52%	-47.33%	68.68%
Enterprise Value	3,222	2,239	351	623	568	2,367
Last Close Price	29.52	23.83	14.89	19.10	20.68	40.47

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	-	53.64
Forward PE	-	13.11	13.11	13.11	13.11	13.11
PS Ratio	32.13	11.94	5.28	12.22	13.37	7.42
PB Ratio	8.08	4.67	2.81	3.10	2.28	3.38
P/TBV Ratio	8.10	4.67	2.81	3.10	2.28	3.38
P/FCF Ratio	-	-	-	-	3.47	-
P/OCF Ratio	-	-	-	-	3.42	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	27.54	9.07	1.36	5.32	5.07	6.18
EV/EBITDA Ratio	-	-	-	-	-	40.82
EV/EBIT Ratio	-	-	-	-	-	43.84
EV/FCF Ratio	-	-	-	-	1.31	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.51	0.35	0.37	0.30	0.18	0.14
Debt / EBITDA Ratio	-	-	-	-	-	1.80
Debt / FCF Ratio	-	-	-	-	0.28	-
Net Debt / Equity Ratio	-1.16	-1.25	-1.67	-1.57	-1.55	-0.67
Net Debt / EBITDA Ratio	1.13	2.10	2.71	2.19	3.72	-9.72
Net Debt / FCF Ratio	1.13	1.63	4.61	2.20	-2.36	2.00
Asset Turnover	0.12	0.22	0.23	0.10	0.08	0.32
Quick Ratio	3.75	4.32	4.44	4.35	5.45	7.51
Current Ratio	3.82	4.36	4.50	4.52	5.53	7.60
Return on Equity (ROE)	-90.82%	-63.26%	-59.77%	-54.87%	-35.62%	7.89%
Return on Assets (ROA)	-30.39%	-21.08%	-17.26%	-17.42%	-11.92%	2.85%
Return on Invested Capital (ROIC)	-	-	-	-	-245.61%	41.81%
Return on Capital Employed (ROCE)	-66.90%	-42.50%	-33.50%	-37.30%	-24.30%	3.80%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-12.24%	-11.97%	-20.77%	-21.47%	-17.83%	1.86%
FCF Yield	-12.64%	-16.41%	-12.92%	-23.08%	28.85%	-9.92%
Buyback Yield / Dilution	-22.85%	-19.20%	-21.76%	-2.78%	2.70%	-35.04%

SEC Filings: 10-K · 10-Q